Biotech · Private company
Vifor (International) Inc.
Track this companyFree. Adds Vifor (International) Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- VIT-2763 120 mgPhase 2 · Sickle Cell DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- VIT-2763 120 mg BIDPhase 2 · Beta-ThalassemiaClinicalTrials.gov · fetched Nov 12, 2026
- VIT-2763 240 mgPhase 2 · Sickle Cell DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- VIT-2763 360 mgPhase 2 · Sickle Cell DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- VIT-2763 60 mg BIDPhase 2 · Beta-ThalassemiaClinicalTrials.gov · fetched Nov 12, 2026
- VIT-2763 60 mg QDPhase 2 · Beta-ThalassemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell DiseasePHASE2 · COMPLETED · started Nov 18, 2021ClinicalTrials.gov NCT04817670 · fetched Nov 12, 2026
- Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemiaPHASE2 · WITHDRAWN · started Sep 20, 2021ClinicalTrials.gov NCT04938635 · fetched Nov 12, 2026
- Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of HyperkalaemiaCOMPLETED · started Apr 19, 2021ClinicalTrials.gov NCT04864795 · fetched Nov 12, 2026